Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹36.82
Market cap: ₹35.57 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.6×Sector 47.3×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 3 Board Meeting Date 3 Management Change 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 May 2026 16:07 IST BSE

Legal & Regulatory

Sandu Pharmaceuticals Legal & Regulatory

Sandu Pharmaceuticals Limited paid a Rs.31,699 penalty to GST authorities in Uttar Pradesh following a detention order for quantity discrepancies in goods. The company accepted the liability on May 6, 2026, leading to the dropping of proceedings. Management stated there is no major financial impact on the company.

Read the filing ↗